CRISPR Therapeutics begins natural killer cell cancer tie-up with NkartaGene editing firm CRISPR Therapeutics has announced a collaboration with US biotech Nkarta to develop natural killer (NK) Share XCRISPR Therapeutics begins natural killer cell cancer tie-up with Nkartahttps://pharmaphorum.com/news/crispr-therapeutics-begins-natural-killer-cell-cancer-tie-up-with-nkarta/
Nobel winner Charpentier’s CRISPR Therapeutics gets $900m in reworked Vertex dealCRISPR Therapeutics is to receive a hefty $900m payment from Vertex after the companies amended a collaboration to Share XNobel winner Charpentier’s CRISPR Therapeutics gets $900m in reworked Vertex dealhttps://pharmaphorum.com/news/nobel-winner-charpentiers-crispr-therapeutics-gets-900m-in-reworked-vertex-deal/
Vertex eyes controllable genetic drugs with $1.3bn Obsidian allianceVertex Pharma has ramped up its involvement in gene-editing medicines for the second time in a week, paying Share XVertex eyes controllable genetic drugs with $1.3bn Obsidian alliancehttps://pharmaphorum.com/news/vertex-eyes-controllable-genetic-drugs-with-1-3bn-obsidian-alliance/
ASH: CRISPR, Vertex’ CTX001 hits the mark in red cell disordersA gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has achieved “remarkable” improvements in patients with beta Share XASH: CRISPR, Vertex’ CTX001 hits the mark in red cell disordershttps://pharmaphorum.com/news/ash-crispr-vertex-ctx001-hits-the-mark-in-red-cell-disorders/
CRISPR trials yield encouraging data in blood disordersData on the first two patients to be treated with a CRISPR-based drug for the blood disorders beta Share XCRISPR trials yield encouraging data in blood disordershttps://pharmaphorum.com/news/crispr-trials-yield-encouraging-data-in-blood-disorders/
FDA gives go-ahead for CRISPR-based sickle cell disease trialDevelopment of a stem cell therapy for sickle cell disease from Vertex and development partner CRISPR therapeutics can Share XFDA gives go-ahead for CRISPR-based sickle cell disease trialhttps://pharmaphorum.com/news/fda-gives-go-ahead-for-crispr-based-sickle-cell-disease-trial/
